Heart failure and kidney dysfunction: epidemiology, mechanisms and management (original) (raw)

• Schocken, D. D. et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 117, 2544–2565 (2008).
  PubMed Google Scholar
• van Riet, E. E. et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur. J. Heart Fail. 18, 242–252 (2016).
  PubMed Google Scholar
• Redfield, M. M. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289, 194–202 (2003).
  PubMed Google Scholar
• Bagshaw, S. M. et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol. Dial. Transplant. 25, 1406–1416 (2010).
  PubMed Google Scholar
• House, A. A. et al. Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol. Dial. Transplant. 25, 1416–1420 (2010).
  PubMed Google Scholar
• Segall, L., Nistor, I. & Covic, A. Heart failure in patients with chronic kidney disease: a systematic integrative review. BioMed Res. Int. 2014, 937398 (2014).
  PubMed PubMed Central Google Scholar
• Mentz, R. J., O'Connor, C. M. Pathophysiology and clinical evaluation of acute heart failure. Nat. Rev. Cardiol. 13, 28–35 (2016).
  CAS PubMed Google Scholar
• Filippatos, G., Farmakis, D. & Parissis, J. Renal dysfunction and heart failure: things are seldom what they seem. Eur. Heart J. 35, 416–418 (2014).
  PubMed Google Scholar
• Mehta, R. L. et al. Acute Kidney Injury Network. Report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).
  PubMed PubMed Central Google Scholar
• Damman, K., Tang, W. H., Testani, J. M. & McMurray, J. J. Terminology and definition of changes renal function in heart failure. Eur. Heart J. 35, 3413–3416 (2014).
  CAS PubMed PubMed Central Google Scholar
• Hogg, K., Swedberg, K. & McMurray, J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J. Am. College Cardiol. 43, 317–327 (2004).
  Google Scholar
• McMurray, J. J. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33, 1787–1847 (2012).
  PubMed Google Scholar
• Ezekowitz, J. et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J. Am. College Cardiol. 44, 1587–1592 (2004).
  Google Scholar
• Hillege, H. L. et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113, 671–678 (2006).
  PubMed Google Scholar
• McAlister, F. A., Ezekowitz, J., Tonelli, M. & Armstrong, P. W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109, 1004–1009 (2004).
  PubMed Google Scholar
• McClellan, W. M., Langston, R. D. & Presley, R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J. Am. Soc. Nephrol. 15, 1912–1919 (2004).
  PubMed Google Scholar
• van Deursen, V. M. et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur. J. Heart Fail. 16, 103–111 (2014).
  PubMed Google Scholar
• Morley, J. E., Anker, S. D. & von Haehling, S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J. Cachexia Sarcopenia Muscle 5, 253–259 (2014).
  PubMed PubMed Central Google Scholar
• Adams, K. F. et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am. Heart J. 149, 209–216 (2005).
  PubMed Google Scholar
• Tonelli, M. et al. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17, 2034–2047 (2006).
  PubMed Google Scholar
• Sud, M., Tangri, N., Pintilie, M., Levey, A. S. & Naimark, D. Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease. Circulation 130, 458–465 (2014).
  PubMed Google Scholar
• Gansevoort, R. T. et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382, 339–352 (2013).
  PubMed Google Scholar
• United States Renal Data System. Chronic kidney disease in the adult NHANES population. USRDS annual report data http://www.usrds.org/2009/pdf/V1_01_09.pdf (2009).
• Levey, A. S. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 80, 17–28 (2011).
  PubMed Google Scholar
• Kottgen, A. et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J. Am. Soc. Nephrol. 18, 1307–1315 (2007).
  CAS PubMed Google Scholar
• Sud, M., Tangri, N., Pintilie, M., Levey, A. S. & Naimark, D. M. ESRD and death after heart failure in CKD. J. Am. Soc. Nephrol. 26, 715–722 (2015).
  PubMed Google Scholar
• Tsuruya, K., Eriguchi, M., Yamada, S., Hirakata, H. & Kitazono, T. Cardio-renal syndrome in end-stage kidney disease. Blood Purif. 40, 337–343 (2015).
  CAS PubMed Google Scholar
• Johnson, D. W., Craven, A. M. & Isbel, N. M. Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial. Int. 11, 1–14 (2007).
  PubMed Google Scholar
• Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl. J. Med. 351, 1296–1305 (2004).
  CAS PubMed Google Scholar
• Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32 (Suppl. 3), S112–S119 (1998).
  CAS PubMed Google Scholar
• Foley, R. N. et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 47, 186–192 (1995).
  CAS PubMed Google Scholar
• Soucie, J. M. & McClellan, W. M. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J. Am. Soc. Nephrol. 7, 2169–2175 (1996).
  CAS PubMed Google Scholar
• Harnett, J. D. et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 47, 884–890 (1995).
  CAS PubMed Google Scholar
• Wang, A. Y. et al. Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis. Clin. J. Am. Soc. Nephrol. 6, 805–812 (2011).
  CAS PubMed PubMed Central Google Scholar
• Basile, D. P., Anderson, M. D. & Sutton, T. A. Pathophysiology of acute kidney injury. Comprehensive Physiol. 2, 1303–1353 (2012).
  Google Scholar
• Berl, T. & Henrich, W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin. J. Am. Soc. Nephrol. 1, 8–18 (2006).
  CAS PubMed Google Scholar
• Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V. & Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365–3370 (2005).
  PubMed Google Scholar
• Nash, K., Hafeez, A. & Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39, 930–936 (2002).
  PubMed Google Scholar
• Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813–818 (2005).
  CAS PubMed Google Scholar
• Bagshaw, S. M., George, C., Dinu, I. & Bellomo, R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol. Dial. Transplant. 23, 1203–1210 (2008).
  PubMed Google Scholar
• Hsu, C. Y. et al. Community-based incidence of acute renal failure. Kidney Int. 72, 208–212 (2007).
  PubMed PubMed Central Google Scholar
• Waikar, S. S., Curhan, G. C., Wald, R., McCarthy, E. P. & Chertow, G. M. Declining mortality in patients with acute renal failure, 1988 to 2002. J. Am. Soc. Nephrol. 17, 1143–1150 (2006).
  PubMed Google Scholar
• Kolhe, N. V., Muirhead, A. W., Wilkes, S. R., Fluck, R. J. & Taal, M. W. The epidemiology of hospitalised acute kidney injury not requiring dialysis in England from 1998 to 2013: retrospective analysis of hospital episode statistics. Int. J. Clin. Practice 70, 330–339 (2016).
  CAS Google Scholar
• Martensson, J. & Bellomo, R. Sepsis-induced acute kidney injury. Crit. Care Clin. 31, 649–660 (2015).
  PubMed Google Scholar
• Rossaint, J. & Zarbock, A. Acute kidney injury: definition, diagnosis and epidemiology. Minerva Urol. Nefrol. 68, 49–57 (2015).
  PubMed Google Scholar
• Damman, K. et al. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur. Heart J. 35, 455–469 (2014).
  PubMed Google Scholar
• Davison, B. A. et al. Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF Studies. JACC Heart Fail. 3, 395–403 (2015).
  PubMed Google Scholar
• Grams, M. E. & Rabb, H. The distant organ effects of acute kidney injury. Kidney Int. 81, 942–948 (2012).
  PubMed Google Scholar
• Metra, M. et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circul. Heart Fail. 5, 54–62 (2012).
  Google Scholar
• Whitman, I. R., Feldman, H. I. & Deo, R. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J. Am. Soc. Nephrol. 23, 1929–1939 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardio-renal syndrome. J. Am. College Cardiol. 52, 1527–1539 (2008).
  Google Scholar
• McCullough, P. A. et al. Pathophysiology of the cardio-renal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib. Nephrol. 182, 82–98 (2013).
  PubMed Google Scholar
• Hadjiphilippou, S. & Kon, S. P. Cardio-renal syndrome: review of our current understanding. J. R. Soc. Med. 109, 12–17 (2016).
  PubMed PubMed Central Google Scholar
• Tsuruya, K. & Eriguchi, M. Cardio-renal syndrome in chronic kidney disease. Curr. Opin. Nephrol. Hypertension 24, 154–162 (2015).
  CAS Google Scholar
• Mall, G., Huther, W., Schneider, J., Lundin, P. & Ritz, E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol. Dial. Transplant. 5, 39–44 (1990).
  CAS PubMed Google Scholar
• Wali, R. K. et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J. Am. College Cardiol. 45, 1051–1060 (2005).
  Google Scholar
• Bock, J. S. & Gottlieb, S. S. Cardio-renal syndrome: new perspectives. Circulation 121, 2592–2600 (2010).
  PubMed Google Scholar
• Waldum, B. & Os, I. The cardio-renal syndrome: what the cardiologist needs to know. Cardiology 126, 175–186 (2013).
  PubMed Google Scholar
• Graziani, G. et al. Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists. Heart Fail. Rev. 19, 699–708 (2014).
  CAS PubMed Google Scholar
• Carlstrom, M., Wilcox, C. S. & Arendshorst, W. J. Renal autoregulation in health and disease. Physiol. Rev. 95, 405–511 (2015).
  CAS PubMed PubMed Central Google Scholar
• Ljungman, S., Laragh, J. H. & Cody, R. J. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39 (Suppl. 4), 10–21 (1990).
  PubMed Google Scholar
• Singh, D. K., Winocour, P. & Farrington, K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat. Clin. Practice Nephrol. 4, 216–226 (2008).
  CAS Google Scholar
• Manotham, K. et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 65, 871–880 (2004).
  PubMed Google Scholar
• Norman, J. T., Clark, I. M. & Garcia, P. L. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 58, 2351–2366 (2000).
  CAS PubMed Google Scholar
• Heywood, J. T. et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J. Cardiac Fail. 13, 422–430 (2007).
  Google Scholar
• Nohria, A. et al. Cardio-renal interactions: insights from the ESCAPE trial. J. Am. College Cardiol. 51, 1268–1274 (2008).
  Google Scholar
• Mullens, W. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. College Cardiol. 53, 589–596 (2009).
  Google Scholar
• Drazner, M. H., Rame, J. E., Stevenson, L. W. & Dries, D. L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. New Engl. J. Med. 345, 574–581 (2001).
  CAS PubMed Google Scholar
• Maeder, M. T., Holst, D. P. & Kaye, D. M. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J. Cardiac Fail. 14, 824–830 (2008).
  Google Scholar
• Mullens, W. et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J. Am. College Cardiol. 51, 300–306 (2008).
  Google Scholar
• Chen, K. P. et al. Peripheral edema, central venous pressure, and risk of AKI in critical illness. Clin. J. Am. Soc. Nephrol. 11, 602–608 (2016).
  CAS PubMed PubMed Central Google Scholar
• Damman, K. et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J. Am. College Cardiol. 53, 582–588 (2009).
  Google Scholar
• Guyton, A. C. Determination of cardiac output by equating venous return curves with cardiac response curves. Physiol. Rev. 35, 123–129 (1955).
  CAS PubMed Google Scholar
• Uemura, K. et al. A novel framework of circulatory equilibrium. Am. J. Physiol. Heart Circulatory Physiol. 286, H2376–2385 (2004).
  CAS Google Scholar
• Magder, S. Point: the classical Guyton view that mean systemic pressure, right atrial pressure, and venous resistance govern venous return is/is not correct. J. Appl. Physiol. 101, 1523–1525 (2006).
  CAS PubMed Google Scholar
• Winton, F. R. The influence of venous pressure on the isolated mammalian kidney. J. Physiol. 72, 49–61 (1931).
  CAS PubMed PubMed Central Google Scholar
• Gottschalk, C. W. & Mylle, M. Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am. J. Physiol. 185, 430–439 (1956).
  CAS PubMed Google Scholar
• Doty, J. M. et al. Effect of increased renal venous pressure on renal function. J. Trauma 47, 1000–1003 (1999).
  CAS PubMed Google Scholar
• Braam, B., Joles, J. A., Danishwar, A. H. & Gaillard, C. A. Cardio-renal syndrome — current understanding and future perspectives. Nat. Rev. Nephrol. 10, 48–55 (2014).
  CAS PubMed Google Scholar
• Ronco, C. et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur. Heart J. 31, 703–711 (2010).
  PubMed Google Scholar
• Damman, K., Voors, A. A., Navis, G., van Veldhuisen, D. J. & Hillege, H. L. The cardio-renal syndrome in heart failure. Prog. Cardiovasc. Dis. 54, 144–153 (2011).
  PubMed Google Scholar
• Afsar, B. et al. Focus on renal congestion in heart failure. Clin. Kidney J. 9, 39–47 (2016).
  CAS PubMed Google Scholar
• Erly, B. et al. Hepatorenal syndrome: a review of pathophysiology and current treatment options. Semin. Intervent. Radiol. 32, 445–454 (2015).
  PubMed PubMed Central Google Scholar
• Verbrugge, F. H. et al. Abdominal contributions to cardio-renal dysfunction in congestive heart failure. J. Am. College Cardiol. 62, 485–495 (2013).
  Google Scholar
• Volpe, M., Carnovali, M. & Mastromarino, V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin. Sci. 130, 57–77 (2016).
  CAS PubMed Google Scholar
• Ruiz-Ortega, M. et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int. Suppl. 82, S12–S22 (2002).
  CAS Google Scholar
• Sharma, U. C. et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110, 3121–3128 (2004).
  CAS PubMed Google Scholar
• de Boer, R. A. et al. Galectin-3 in heart failure with preserved ejection fraction. Eur. J. Heart Fail. 15, 1095–1101 (2013).
  CAS PubMed Google Scholar
• AbouEzzeddine, O.F. et al. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (phosphodiesterase-5 inhibition to improve clinical status and exercise capacity in diastolic heart failure). JACC Heart Fail. 3, 245–252 (2015).
  PubMed PubMed Central Google Scholar
• Shenker, Y., Sider, R. S., Ostafin, E. A. & Grekin, R. J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J. Clin. Invest. 76, 1684–1687 (1985).
  CAS PubMed PubMed Central Google Scholar
• Trimarco, B. et al. Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor. Circulation 80, 883–892 (1989).
  CAS PubMed Google Scholar
• Volpe, M. et al. Carotid baroreceptor unloading decreases plasma atrial natriuretic factor in hypertensive patients. J. Hypertension 4, S519–S522 (1986).
  CAS Google Scholar
• von Haehling, S. et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J. Am. College Cardiol. 50, 1973–1980 (2007).
  CAS Google Scholar
• Gegenhuber, A. et al. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin. Chem. 52, 827–831 (2006).
  CAS PubMed Google Scholar
• Moertl, D. et al. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. J. Am. College Cardiol. 53, 1783–1790 (2009).
  CAS Google Scholar
• Voors, A. A. et al. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur. Heart J. 30, 1187–1194 (2009).
  CAS PubMed Google Scholar
• Farmakis, D., Filippatos, G., Kremastinos, D. T. & Gheorghiade, M. Vasopressin and vasopressin antagonists in heart failure and hyponatremia. Curr. Heart Fail. Rep. 5, 91–96 (2008).
  CAS PubMed Google Scholar
• Grassi, G. et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57, 846–851 (2011).
  CAS PubMed Google Scholar
• Zoccali, C. et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105, 1354–1359 (2002).
  CAS PubMed Google Scholar
• Dibona, G. F., Jones, S. Y. & Sawin, L. L. Reflex influences on renal nerve activity characteristics in nephrosis and heart failure. J. Am. Soc. Nephrol. 8, 1232–1239 (1997).
  CAS PubMed Google Scholar
• DiBona, G. F. & Kopp, U. C. Neural control of renal function. Physiol. Rev. 77, 75–197 (1997).
  CAS PubMed Google Scholar
• Ramchandra, R. & Barrett, C. J. Regulation of the renal sympathetic nerves in heart failure. Frontiers Physiol. 6, 238 (2015).
  Google Scholar
• Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275–1281 (2009).
  PubMed Google Scholar
• Schepers, E. et al. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 2374–2383 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bongartz, L. G. et al. Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R815–R823 (2010).
  CAS PubMed Google Scholar
• Bongartz, L. G. et al. Subtotal nephrectomy plus coronary ligation leads to more pronounced damage in both organs than either nephrectomy or coronary ligation. Am. J. Physiol. Heart Circulatory Physiol. 302, H845–H854
  CAS PubMed Google Scholar
• Voors, A. A. et al. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the selective adenosine A1 receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function). J. Am. College Cardiol. 57, 1899–1907 (2011).
  CAS Google Scholar
• Kato, S. et al. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 3, 1526–1533 (2008).
  PubMed PubMed Central Google Scholar
• Machowska, A., Carrero, J. J., Lindholm, B. & Stenvinkel, P. Therapeutics targeting persistent inflammation in chronic kidney disease. Translat. Res. 167, 204–213 (2016).
  CAS Google Scholar
• von Haehling, S. et al. Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure. PLoS ONE 4, e6411 (2009).
  PubMed PubMed Central Google Scholar
• Stenvinkel, P., Heimburger, O., Lindholm, B., Kaysen, G.A. & Bergstrom, J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol. Dial. Transplant. 15, 953–960 (2000).
  CAS PubMed Google Scholar
• Silverberg, D. S., Wexler, D., Blum, M. & Iaina, A. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin. Nephrol. 60 (Suppl. 1), S93–S102 (2003).
  PubMed Google Scholar
• Silverberg, D. S. et al. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol. Dial. Transplant. 18, 141–146 (2003).
  CAS PubMed Google Scholar
• Kidney disease: improving global outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 113, S1–S130 (2009).
• Mangner, N. et al. Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm. J. Cachexia Sarcopenia Muscle 6, 381–390 (2015).
  PubMed PubMed Central Google Scholar
• Josiak, K., Jankowska, E. A., Piepoli, M. F., Banasiak, W. & Ponikowski, P. Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones. J. Cachexia, Sarcopenia Muscle 5, 287–296 (2014).
  Google Scholar
• von Haehling, S., Schefold, J. C., Lainscak, M., Doehner, W. & Anker, S. D. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Fail. Clin. 5, 549–560 (2009).
  PubMed Google Scholar
• Colombo, P. C. et al. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardio-renal syndrome. Heart Fail. Rev. 17, 177–190 (2012).
  CAS PubMed Google Scholar
• Stenvinkel, P. & Larsson, T. E. Chronic kidney disease. a clinical model of premature aging. Am. J. Kidney Diseases 62, 339–351 (2013).
  Google Scholar
• Kooman, J. P., Kotanko, P., Schols, A. M., Shiels, P. G. & Stenvinkel, P. Chronic kidney disease and premature ageing. Nat. Rev. Nephrol. 10, 732–742 (2014).
  CAS PubMed Google Scholar
• Schefold, J. P. et al. Increased Indoleamine 2,3-Dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol. Dial. Transplant. 24, 1901–1908 (2009).
  CAS PubMed Google Scholar
• Kitai, T., Kirsop, J. & Tang, W. H. Exploring the Microbiome in Heart Failure. Curr. Heart Fail. Rep. 13, 103–109 (2016).
  CAS PubMed PubMed Central Google Scholar
• Barreto, D. V. et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 77, 550–556 (2010).
  CAS PubMed Google Scholar
• Ismahil, M. A. et al. Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circul. Res. 114, 266–282 (2014).
  CAS Google Scholar
• Hoffmann, J. et al. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients. Circul. Res. 116, 87–98 (2015).
  CAS Google Scholar
• von Haehling, S. The wasting continuum in heart failure: from sarcopenia to cachexia. Proc. Nutr. Soc. 74, 367–377 (2015).
  PubMed Google Scholar
• Ebner, N., Elsner, S., Springer, J. & von Haehling, S. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview. Curr. Opin. Supportive Palliative Care 8, 15–24 (2014).
  PubMed Google Scholar
• Ebner, N. et al. Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas 75, 199–206 (2013).
  CAS PubMed Google Scholar
• von Haehling, S., Lainscak, M., Springer, J. & Anker, S. D. Cardiac cachexia: a systematic overview. Pharmacol. Ther. 121, 227–252 (2009).
  CAS PubMed Google Scholar
• von Haehling, S., Steinbeck, L., Doehner, W., Springer, J. & Anker, S. D. Muscle wasting in heart failure: an overview. Int. J. Biochem. Cell Biol. 45, 2257–2265 (2013).
  CAS PubMed Google Scholar
• Pecoits-Filho, R., Lindholm, B. & Stenvinkel, P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome — the heart of the matter. Nephrol. Dial. Transpl. 17 (Suppl. 11), 28–31 (2002).
  CAS Google Scholar
• Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D. & Alexander, R. W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circul. Res. 74, 1141–1148 (1994).
  CAS Google Scholar
• Heymes, C. et al. Increased myocardial NADPH oxidase activity in human heart failure. J. Am. College Cardiol. 41, 2164–2171 (2003).
  CAS Google Scholar
• Vaziri, N. D., Dicus, M., Ho, N. D., Boroujerdi-Rad, L. & Sindhu, R. K. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 63, 179–185 (2003).
  CAS PubMed Google Scholar
• Munzel, T., Gori, T. & Keaney, J. F. Jr., Maack, C. & Daiber, A. Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur. Heart J. 36, 2555–2564 (2015).
  PubMed Google Scholar
• Ratcliffe, P. J. From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway. Blood Purif. 20, 445–450 (2002).
  CAS PubMed Google Scholar
• Pschowski, R. et al. Effects of dialysis modality on blood loss, bleeding complications and transfusion requirements in critically ill patients with dialysis-dependent acute renal failure. Anaesth. Intensive Care 43, 764–770 (2015).
  CAS PubMed Google Scholar
• Lin, C. L. et al. Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use. Ther. Apher. Dial. 18, 51–56 (2014).
  CAS PubMed Google Scholar
• Groenveld, H. F. et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J. Am. College Cardiol. 52, 818–827 (2008).
  Google Scholar
• Maggioni, A. P. et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J. Cardiac Fail. 11, 91–98 (2005).
  Google Scholar
• Kawashiro, N. et al. Clinical characteristics and outcome of hospitalized patients with congestive heart failure: results of the HIJC-HF registry. Circul. J. 72, 2015–2020 (2008).
  Google Scholar
• Young, J. B. et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am. J. Cardiol. 101, 223–230 (2008).
  CAS PubMed Google Scholar
• von Haehling, S. et al. Anaemia is an independent predictor of death in patients hospitalized for acute heart failure. Clin. Res. Cardiol. 99, 107–113 (2010).
  PubMed Google Scholar
• von Haehling, S. et al. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study. Eur. J. Heart Fail. 13, 656–663 (2011).
  PubMed Google Scholar
• van der Meer, P., Groenveld, H. F. & Januzzi, J. L. Jr., van Veldhuisen, D. J. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95, 1309–1314 (2009).
  CAS PubMed Google Scholar
• Anker, S. D. et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. New Engl. J. Med. 361, 2436–2448 (2009).
  CAS PubMed Google Scholar
• Ponikowski, P. et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger. Eur. Heart J. 36, 657–668 (2015).
  CAS PubMed Google Scholar
• von Haehling, S., Jankowska, E. A., van Veldhuisen, D. J., Ponikowski, P. & Anker, S. D. Iron deficiency and cardiovascular disease. Nat. Rev. Cardiol. 12, 659–669 (2015).
  CAS PubMed Google Scholar
• Levin, A. et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am. J. Kidney Dis. 34, 125–134 (1999).
  CAS PubMed Google Scholar
• Calvillo, L. et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl Acad. Sci. USA 100, 4802–4806 (2003).
  CAS PubMed Google Scholar
• Charytan, D. M., Fishbane, S., Malyszko, J., McCullough, P. A. & Goldsmith, D. Cardio-renal syndrome and the role of the bone-mineral axis and anemia. Am. J. Kidney Dis. 66, 196–205 (2015).
  PubMed PubMed Central Google Scholar
• Kovesdy, C. P. & Quarles, L. D. The role of fibroblast growth factor-23 in cardio-renal syndrome. Nephron Clin. Pract. 123, 194–201 (2013).
  CAS PubMed PubMed Central Google Scholar
• Achinger, S. G. & Ayus, J. C. Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor? J. Am. Soc. Nephrol. 17 S255–S261 (2006).
  CAS PubMed Google Scholar
• Fujii, H., Kim, J. I., Abe, T., Umezu, M. & Fukagawa, M. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients. Internal Med. 46, 1507–1512 (2007).
  Google Scholar
• Scialla, J. J. & Wolf, M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat. Rev. Nephrol. 10, 268–278 (2014).
  CAS PubMed Google Scholar
• Rozentryt, P. et al. Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure. J. Cachexia Sarcopenia Muscle 6, 325–334 (2015).
  PubMed PubMed Central Google Scholar
• Moe, S. M. et al. Cinacalcet, Fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Circulation 132, 27–39 (2015).
  CAS PubMed Google Scholar
• Wang, A. Y. et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am. J. Clin. Nutr. 87, 1631–1638 (2008).
  CAS PubMed Google Scholar
• Panizo, S. et al. Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis. Nephrol. Dial. Transplant. 28, 2735–2744 (2013).
  CAS PubMed Google Scholar
• de Zeeuw, D. et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376, 1543–1551 (2010).
  CAS PubMed Google Scholar
• Thadhani, R. et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307, 674–684 (2012).
  CAS PubMed Google Scholar
• Garg, N. et al. Cardiac resynchronization therapy in CKD: a systematic review. Clin. J. Am. Soc. Nephrol. 8, 1293–1303 (2013).
  PubMed PubMed Central Google Scholar
• Kidney disease: improving global outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2, 9–335 (2012).
• Gastelurrutia, P. et al. Body mass index, body fat, and nutritional status of patients with heart failure: The PLICA study. Clin. Nutr. 34, 1233–1238 (2015).
  PubMed Google Scholar
• Khalid, U. et al. Pre-morbid body mass index and mortality after incident heart failure: the ARIC study. J. Am. College Cardiol. 64, 2743–2749 (2014).
  Google Scholar
• Rozentryt, P. et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J. Cachexia Sarcopenia Muscle 1, 35–42 (2010).
  PubMed PubMed Central Google Scholar
• Witte, K. K. et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur. Heart J. 26, 2238–2244 (2005).
  CAS PubMed Google Scholar
• Valentova, M. et al. Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure. Eur. Heart J. 37, 1684–1691 (2016).
  PubMed Google Scholar
• [No authors listed] Retraction. Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis. Heart 99, 820 (2013).
• DiNicolantonio, J. J., Di Pasquale, P., Taylor, R. S. & Hackam, D. G. Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis. Heart http://dx.doi.org/10.1136/heartjnl-2012-302337 (2013).
• Kidney disease: improving global outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2, 337–414 (2012).
• McMurray, J. J. et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. New Engl. J. Med. 371, 993–1004 (2014).
  PubMed Google Scholar
• Eshaghian, S., Horwich, T. B. & Fonarow, G. C. Relation of loop diuretic dose to mortality in advanced heart failure. Am. J. Cardiol. 97, 1759–1764 (2006).
  CAS PubMed Google Scholar
• ter Maaten, J. M. et al. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat. Rev. Cardiol. 12, 184–192 (2015).
  CAS PubMed Google Scholar
• Costanzo, M. R., Fonarow, G. C. & Filippatos, G. S. Ultrafiltration in heart failure with cardio-renal syndrome. New Engl. J. Med. 368, 1158–1159 (2013).
  PubMed Google Scholar
• US National Library of Medicine. ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT00577135?term=NCT00577135&rank=1 (2016).
• US National Library of Medicine. ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01921829?term=NCT01921829&rank=1 (2016).
• Lala, A. et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardio-renal rescue study in acute decompensated heart failure (CARESS-HF). Circul. Heart Fail. 8, 741–748 (2015).
  Google Scholar
• Yancy, C. W. et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128, 1810–1852 (2013).
  PubMed Google Scholar
• Lins, R. L. et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol. Dial. Transplant. 24, 512–518 (2009).
  PubMed Google Scholar
• Schefold, J.C. et al. The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit. Care 18, R11 (2014).
  PubMed PubMed Central Google Scholar
• Vinsonneau, C. et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368, 379–385 (2006).
  PubMed Google Scholar
• Zarbock, A. et al. Randomized Clinical Trial. JAMA 20, 2190–2199 (2016).
  Google Scholar
• Seabra, V. F. et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am. J. Kidney Dis. 52, 272–284 (2008).
  PubMed Google Scholar
• Kellum, J. A. & Ronco, C. Dialysis: results of RENAL — what is the optimal CRRT target dose? Nat. Rev. Nephrol. 6, 191–192 (2010).
  PubMed Google Scholar
• Kidney disease: improving global outcomes (KDIGO). KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2, 1–138 (2012).
• Lin, T. E., Adams, K. F. Jr. & Patterson, J.H. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients. Heart Fail. Clin. 10, 607–620 (2014).
  PubMed Google Scholar
• Lehrich, R. W., Ortiz-Melo, D. I., Patel, M. B. & Greenberg, A. Role of vaptans in the management of hyponatremia. Am. J. Kidney Dis. 62, 364–376 (2013).
  CAS PubMed Google Scholar
• Konstam, M. A. et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297, 1319–1331 (2007).
  CAS PubMed Google Scholar
• Morooka, H. et al. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure. Circul. Heart Fail. 5, 484–492 (2012).
  CAS Google Scholar
• Cannella, G. et al. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am. J. Kidney Dis. 30, 659–664 (1997).
  CAS PubMed Google Scholar
• O'Connor, C. M. et al. Effect of nesiritide in patients with acute decompensated heart failure. New Engl. J. Med. 365, 32–43 (2011).
  CAS PubMed Google Scholar
• van Deursen, V. M. et al. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation 130, 958–965 (2014).
  CAS PubMed Google Scholar
• Singh, A., Laribi, S., Teerlink, J. R. & Mebazaa, A. Agents with vasodilator properties in acute heart failure. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehv755 (2013).
• Teerlink, J. R. et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29–39 (2013).
  CAS PubMed Google Scholar
• Metra, M. et al. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J. Am. College Cardiol. 61, 196–206 (2013).
  CAS Google Scholar
• Nimmo, A. J., Than, N., Orchard, C. H. & Whitaker, E. M. The effect of acidosis on β-adrenergic receptors in ferret cardiac muscle. Exp. Physiol. 78, 95–103 (1993).
  CAS PubMed Google Scholar
• Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 27, 2129–200 (2016).
  Google Scholar